Amneal Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Amneal Pharmaceuticals Class
AMRX Stock  USD 13.23  0.04  0.30%   
Amneal Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amneal Pharmaceuticals' valuation are provided below:
Gross Profit
1.1 B
Profit Margin
0.002
Market Capitalization
4.1 B
Enterprise Value Revenue
2.2657
Revenue
2.9 B
We have found one hundred twenty available fundamental signals for Amneal Pharmaceuticals Class, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Amneal Pharmaceuticals Class prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 4.8 B in 2026, whereas Market Cap is likely to drop slightly above 1.2 B in 2026.

Amneal Pharmaceuticals Total Revenue

1.85 Billion

Check Amneal Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 164.4 M, Interest Expense of 312.3 M or Selling General Administrative of 296.8 M, as well as many indicators such as Price To Sales Ratio of 0.96, Dividend Yield of 0.0728 or Days Sales Outstanding of 132. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Amneal Stock
Check out the analysis of Amneal Pharmaceuticals Correlation against competitors.

Amneal Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 B4 B2.8 B
Slightly volatile
Common Stock Shares Outstanding187.8 M355.3 M186.9 M
Slightly volatile
Short and Long Term Debt Total2.6 B3 B2 B
Slightly volatile
Other Current Liabilities357.9 M609.1 M280.5 M
Slightly volatile
Total Current Liabilities654.4 M1.3 B535.2 M
Slightly volatile
Other Liabilities75 M111.7 M57.2 M
Slightly volatile
Property Plant And Equipment Net581.3 M602.2 M474.3 M
Slightly volatile
Net Debt2.4 B2.9 B1.9 B
Slightly volatile
Accounts Payable313.8 M298.8 M131.5 M
Slightly volatile
Cash147.9 M127.1 M113.2 M
Slightly volatile
Non Current Assets Total2 B2.2 B1.4 B
Slightly volatile
Other Assets19.3 M20.3 M74.3 M
Pretty Stable
Long Term Debt2.2 B2.5 B1.6 B
Slightly volatile
Cash And Short Term Investments149.9 M129.3 M116 M
Slightly volatile
Net Receivables625.5 M892.1 M504.3 M
Slightly volatile
Good Will422.5 M687.1 M300 M
Slightly volatile
Short Term Investments1.9 M1.7 M3 M
Slightly volatile
Long Term Debt Total2.1 B3 B1.6 B
Slightly volatile
Non Current Liabilities Total2.5 B2.8 B1.9 B
Slightly volatile
Capital Surpluse648.3 M795.4 M591.9 M
Slightly volatile
Inventory476.1 M704.3 M393.1 M
Slightly volatile
Other Current Assets79.1 M100.3 M61.6 M
Slightly volatile
Total Liabilities3.2 B4.1 B2.5 B
Slightly volatile
Short and Long Term Debt391.5 M372.8 M98.2 M
Slightly volatile
Total Current Assets1.3 B1.8 B1.1 B
Slightly volatile
Short Term Debt410.9 M391.3 M124.8 M
Slightly volatile
Intangible Assets920.5 M842.2 M610.6 M
Slightly volatile
Common Stock3.2 M3.6 M2.9 M
Slightly volatile
Property Plant Equipment513.5 M540.3 M399.9 M
Slightly volatile
Current Deferred Revenue481.1 M458.2 M261.4 M
Slightly volatile
Common Stock Total Equity2.8 M3.5 M1.6 M
Slightly volatile
Liabilities And Stockholders Equity3.9 B4 B2.7 B
Slightly volatile
Capital Lease Obligations111 M123.2 M77.8 M
Slightly volatile
Net Invested Capital2.9 B2.7 B2 B
Slightly volatile
Property Plant And Equipment Gross772.5 M1.3 B649.9 M
Slightly volatile
Non Current Liabilities Other146.1 M108.2 M80.7 M
Slightly volatile
Net Working Capital523.3 M412.2 M558.5 M
Pretty Stable
Capital Stock3.3 M3.6 M3.1 M
Slightly volatile
Long Term Investments13.1 M14.7 M16.1 M
Slightly volatile
Warrants19.7 M28.7 M15.9 M
Slightly volatile

Amneal Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization164.4 M271.6 M127.1 M
Slightly volatile
Selling General Administrative296.8 M508.3 M241.9 M
Slightly volatile
Total Revenue1.8 B3.2 B1.6 B
Slightly volatile
Gross Profit721.5 M1.2 B641.7 M
Slightly volatile
Other Operating Expenses1.7 B2.9 B1.4 B
Slightly volatile
Research Development204.7 M219.3 M170.5 M
Slightly volatile
Cost Of Revenue1.1 B2 B927.9 M
Slightly volatile
Total Operating Expenses565.5 M886.8 M474.5 M
Slightly volatile
Interest Income103.3 M199.1 M107.9 M
Slightly volatile
Reconciled Depreciation215.2 M271.6 M139.6 M
Slightly volatile
Extraordinary Items240 K180 K295.3 K
Slightly volatile
Preferred Stock And Other Adjustments645.6 K394.2 K838.3 K
Slightly volatile
Non Recurring348.6 M332 M148.3 M
Slightly volatile
Selling And Marketing Expenses23.3 M39.6 M19.3 M
Slightly volatile

Amneal Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow149 M114 M122.4 M
Slightly volatile
Depreciation165.3 M271.6 M127.7 M
Slightly volatile
Capital Expenditures70.9 M67.5 M84.1 M
Slightly volatile
Total Cash From Operating Activities214.5 M339.4 M185.2 M
Slightly volatile
End Period Cash Flow152.2 M136.2 M134.2 M
Pretty Stable
Change To Netincome170.7 M151.9 M119 M
Slightly volatile
Stock Based Compensation31.2 M25 M31.5 M
Very volatile
Cash Flows Other Operating217.5 M287.6 M191 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.961.013.3695
Slightly volatile
Dividend Yield0.07280.09570.0837
Slightly volatile
Days Sales Outstanding132117119
Very volatile
Operating Cash Flow Per Share0.970.861.0297
Slightly volatile
Stock Based Compensation To Revenue0.01090.01140.059
Slightly volatile
Capex To Depreciation0.350.371.9846
Slightly volatile
EV To Sales3.282.035.1309
Slightly volatile
Inventory Turnover1.922.612.1396
Slightly volatile
Days Of Inventory On Hand178145183
Slightly volatile
Payables Turnover6.816.147.3091
Slightly volatile
Sales General And Administrative To Revenue0.110.140.1374
Slightly volatile
Research And Ddevelopement To Revenue0.130.07850.1249
Slightly volatile
Capex To Revenue0.02930.03090.0707
Slightly volatile
Cash Per Share0.310.330.6722
Pretty Stable
POCF Ratio9.069.5446.6641
Pretty Stable
Capex To Operating Cash Flow0.280.293.9138
Very volatile
Days Payables Outstanding49.9161.553.6964
Slightly volatile
EV To Operating Cash Flow18.2519.21154
Very volatile
Intangibles To Total Assets0.260.340.2536
Slightly volatile
Current Ratio2.451.622.296
Slightly volatile
Receivables Turnover2.463.243.074
Very volatile
Capex Per Share0.270.280.4941
Pretty Stable
Revenue Per Share8.248.148.6059
Slightly volatile
Interest Debt Per Share12.598.3112.0634
Slightly volatile
Debt To Assets0.90.850.8801
Slightly volatile
Graham Number3.992.274.2487
Slightly volatile
Short Term Coverage Ratios0.991.052.919
Very volatile
Operating Cycle310262302
Slightly volatile
Days Of Payables Outstanding49.9161.553.6964
Slightly volatile
Price To Operating Cash Flows Ratio9.069.5446.6641
Pretty Stable
Long Term Debt To Capitalization1.121.211.1094
Slightly volatile
Total Debt To Capitalization1.121.21.0999
Slightly volatile
Quick Ratio1.570.991.4464
Slightly volatile
Dividend Paid And Capex Coverage Ratio3.723.541.8746
Slightly volatile
Cash Ratio0.110.09790.2291
Slightly volatile
Cash Conversion Cycle261200249
Slightly volatile
Operating Cash Flow Sales Ratio0.130.120.1272
Pretty Stable
Days Of Inventory Outstanding178145183
Slightly volatile
Days Of Sales Outstanding132117119
Very volatile
Cash Flow Coverage Ratios0.10.130.0983
Very volatile
Fixed Asset Turnover2.644.83.1796
Slightly volatile
Capital Expenditure Coverage Ratio2.093.542.3533
Slightly volatile
Price Cash Flow Ratio9.069.5446.6641
Pretty Stable
Debt Ratio0.90.850.8801
Slightly volatile
Cash Flow To Debt Ratio0.10.130.0983
Very volatile
Price Sales Ratio0.961.013.3695
Slightly volatile
Asset Turnover0.70.920.7221
Slightly volatile
Gross Profit Margin0.460.420.4605
Slightly volatile

Amneal Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.2 B1.2 B3 B
Slightly volatile
Enterprise Value4.8 B4.3 B5.6 B
Slightly volatile

Amneal Fundamental Market Drivers

Forward Price Earnings6.2972
Cash And Short Term Investments112.4 M

Amneal Upcoming Events

7th of March 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Amneal Pharmaceuticals Financial Statements

Amneal Pharmaceuticals investors use historical fundamental indicators, such as Amneal Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue458.2 M481.1 M
Total Revenue3.2 B1.8 B
Cost Of Revenue2 B1.1 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.14  0.11 
Research And Ddevelopement To Revenue 0.08  0.13 
Capex To Revenue 0.03  0.03 
Revenue Per Share 8.14  8.24 
Ebit Per Revenue 0.10  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY